FDA Inspection 1109935 — Eurofins BioPharma Product Testing Hamburg GmbH

Eurofins BioPharma Product Testing Hamburg GmbH — FEI 3010166293

The FDA completed an inspection of Eurofins BioPharma Product Testing Hamburg GmbH on September 18, 2019 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hamburg (Germany)